Professor of Oncology, Professor of Medicine, Professor of Pathology, Johns Hopkins University School of Medicine; Director, Division of Hematologic Malignancies, Program Leader, Hematologic Malignancies and Bone Marrow Transplant, James B. Murphy Profess

Oncology

Doctor Richard F. Ambinder, MD practices Oncology. He went to medical school at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a one of the best medicals schools. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine He received 7 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer", "Top Doctors:Baltimore Area", "Top Doctors:Washington-Baltimore", "Elected Member" and "Super Doctor". Richard Ambinder is a published doctor. He published 14 publications, including: 'Risk-stratified outcomes of nonmyeloablative, HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.' He accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• Risk-stratified outcomes of nonmyeloablative, HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.
• Post-transplantation cyclophosphamide as single-agent GVHD prophylaxis after myeloablative conditioning and HLA-matched allografting for Acute leukemias and myelodyspl...
• Active Idiotypic Vaccination Versus Control Immunotherapy for Follicular Lymphoma.
• Sustained remission and reversal of end-organ dysfunction in a patient with Anaplastic myeloma.
• Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-vers...
• Bortezomib salvage therapy in refractory Acute adult T-cell leukemia/lymphoma.
• EBV-Related Lymphomas: New Approaches to Treatment.
• Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/Leukemia.
• Hematopoietic stem Cell transplantation in HIV-1-infected individuals: clinical challenges and the potential for viral eradication.
• Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin Lymphoma: correlative analysis from a large North American co-operative group trial.
• Outcomes of Related Donor HLA-Identical or HLA-Haploidentical Allogeneic Blood or Marrow Transplantation for Peripheral T Cell Lymphoma.
• Human leukocyte antigen-haploidentical hematopoietic stem cell transplant for a patient with histiocytic Sarcoma.
• Circulating clonotypic B cells in classic Hodgkin Lymphoma.

Schools

---

• Johns Hopkins University School of Medicine

• Johns Hopkins Hospital

Procedures Preformed

---

• HPC Transplantation (Stem Cell Transplant)
• Plasmapheresis
• Thoracentesis

Conditions Treated

---

• Acute Leukemia
• Anemia
• Breast Cancer
• Carcinoma in Situ
• View All

Doctors Specialties

---

• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• America's Top Doctors
• CMS Meaningful Use Stage 1 Certification
• America's Top Doctors for Cancer
• Top Doctors:Baltimore Area
• Top Doctors:Washington-Baltimore
• Elected Member
• Super Doctor

Education

---

• Johns Hopkins University
• Johns Hopkins University School of Medicine

Hospital

---

• Johns Hopkins Hospital

Drug Facts

---

NPI NUMBER		1528022407
NPPES Provider LastName		AMBINDER
NPPES Provider FirstName		RICHARD
NPPES Provider ZIPCode		212870005
NPPES Provider State		MD
Specialty Description		Medical Oncology
Total Claim Count		108.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1528022407
Last Name Of The Provider	AMBINDER
First Name Of The Provider	RICHARD
View All

Similar Doctors

---

	Dr. Mian K. Khalid, MD This Doctor is OpenDoctor Recommended.
	Dr. Heather D. Mannuel, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Mark J. Levis, MD This Doctor is OpenDoctor Recommended. This doctor has more publications

---

Doctor Directory | TOS | twitter | FB | Angel | blog